Response surface methodology applied to the generation of casein hydrolysates with antioxidant and dipeptidyl peptidase IV inhibitory properties

Journal of the Science of Food and Agriculture

Volumn 97, Issue 4, 2017, Pages 1093-1101

  Nongonierma, Alice B ^a   Maux, Solène Le ^a   Esteveny, Claire ^a   FitzGerald, Richard J ^a  

^a UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

antioxidant; bioactive peptides; casein; dipeptidyl peptidase IV inhibition; response surface methodology

Indexed keywords

ANTIDIABETIC AGENT; ANTIOXIDANT; CASEIN; CASEIN HYDROLYSATE; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE BLOOD LEVEL; MILK PROTEIN; PEPTIDE HYDROLASE; PROTEIN HYDROLYSATE;

ANIMAL; BACILLUS; BIOSYNTHESIS; ENZYMOLOGY; GLUCOSE BLOOD LEVEL; HUMAN; HYDROLYSIS; METABOLISM; PIG; TEMPERATURE;

ANIMALS; ANTIOXIDANTS; BACILLUS; BLOOD GLUCOSE; CASEINS; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HUMANS; HYDROLYSIS; HYPOGLYCEMIC AGENTS; MILK PROTEINS; PEPTIDE HYDROLASES; PROTEIN HYDROLYSATES; SWINE; TEMPERATURE;

EID: 84979020963     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.7834     Document Type: Article

References (57)

1. Brandelli A, Daroit DJ and Corrêa APF, Whey as a source of peptides with remarkable biological activities. Food Res Int 73:149–161 (2015).
2. Hernández-Ledesma B, García-Nebot MJ, Fernández-Tomé S, Amigo L and Recio I, Dairy protein hydrolysates: Peptides for health benefits. Int Dairy J 38:82–100 (2014).
3. Kanekanian A, The health benefits of bioactive compounds from milk and dairy products, in Milk and Dairy Products as Functional Foods, ed. by Kanekanian A. Wiley Blackwell, Oxford, pp. 1–22 (2014).
4. Nongonierma AB and FitzGerald RJ, Milk proteins as a source of tryptophan-containing bioactive peptides. Food Funct 6:2115–2127 (2015).
5. International Diabetes Federation (IDF), Diabetes Atlas, 6th edition. IDF (2014). Available: http://www.idf.org/diabetesatlas/update-2014 [21 November 2015].
6. Ravassa S, Beaumont J, Huerta A, Barba J, Coma-Canella I, González A, et al., Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: A pilot study. Free Radical Biol Med 81:1–12 (2015).
7. Juillerat-Jeanneret L, Dipeptidyl peptidase IV and its inhibitors: Therapeutics for type 2 diabetes and what else? J Med Chem 57:2197–2212 (2014).
8. Jao C-L, Hung C-C, Tung Y-S, Lin P-Y, Chen M-C and Hsu K-C, The development of bioactive peptides from dietary proteins as a dipeptidyl peptidase IV inhibitor for the management of type 2 diabetes. BioMedicine 5:9–15 (2015).
9. Nongonierma AB and FitzGerald RJ, Prospects for the management of type 2 diabetes using food protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity. Curr Opin Food Sci 8:19–24 (2016).
10. Power O, Jakeman P and FitzGerald RJ, Antioxidative peptides: enzymatic production, in vitro and in vivo antioxidant activity and potential applications of milk-derived antioxidative peptides. Amino Acids 44:797–820 (2013).
11. de Castro RJS and Sato HH, Biologically active peptides: Processes for their generation, purification and identification and applications as natural additives in the food and pharmaceutical industries. Food Res Int 74:185–198 (2015).
12. Naik L, Mann B, Bajaj R, Sangwan R and Sharma R, Process optimization for the production of bio-functional whey protein hydrolysates: Adopting response surface methodology. Int J Pept Res Ther 19:231–237 (2013).
13. Quirós A, Hernández-Ledesma B, Ramos M, Martín-Álvarez PJ and Recio I, Production of antihypertensive peptide HLPLP by enzymatic hydrolysis: Optimization by response surface methodology. J Dairy Sci 95:4280–4285 (2012).
14. van der Ven C, Gruppen H, de Bont DBA and Voragen AGJ, Optimisation of the angiotensin converting enzyme inhibition by whey protein hydrolysates using response surface methodology. Int Dairy J 12:813–820 (2002).
15. Zheng H, Shen X, Bu G and Luo Y, Effects of pH, temperature and enzyme-to-substrate ratio on the antigenicity of whey protein hydrolysates prepared by Alcalase. Int Dairy J 18:1028–1033 (2008).
16. Tulipano G, Faggi L, Nardone A, Cocchi D and Caroli AM, Characterisation of the potential of β-lactoglobulin and α-lactalbumin as sources of bioactive peptides affecting incretin function: In silico and in vitro comparative studies. Int Dairy J 48:62–72 (2015).
17. Nongonierma AB and FitzGerald RJ, Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk-derived dipeptides and hydrolysates. Peptides 39:157–163 (2013).
18. Lacroix IME and Li-Chan ECY, Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates. Int Dairy J 25:97–102 (2012).
19. Connolly A, Piggott CO and FitzGerald RJ, In vitro α-glucosidase, angiotensin converting enzyme and dipeptidyl peptidase-IV inhibitory properties of brewers' spent grain protein hydrolysates. Food Res Int 56:100–107 (2014).
20. Nongonierma AB and FitzGerald RJ, Investigation of the potential of hemp, pea, rice and soy protein hydrolysates as a source of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides. Food Dig 6:19–29 (2015).
21. Sila A, Martinez-Alvarez O, Haddar A, Gómez-Guillén MC, Nasri M, Montero MP, et al., Recovery, viscoelastic and functional properties of Barbel skin gelatine: Investigation of anti-DPP-IV and anti-prolyl endopeptidase activities of generated gelatine polypeptides. Food Chem 168:478–486 (2015).
22. Nongonierma AB, Le Maux S, Dubrulle C, Barre C and FitzGerald RJ, Quinoa (Chenopodium quinoa Willd.) protein hydrolysates with in vitro dipeptidyl peptidase IV (DPP-IV) inhibitory and antioxidant properties. J Cereal Sci 65:112–118 (2015).
23. Adler-Nissen J, Enzymic Hydrolysis of Food Proteins. Elsevier Applied Science Publishers, London (1986).
24. Nongonierma AB and FitzGerald RJ, Tryptophan-containing milk protein-derived dipeptides inhibit xanthine oxidase. Peptides 37:263–272 (2012).
25. Spellman D, O'Cuinn G and FitzGerald RJ, Bitterness in Bacillus proteinase hydrolysates of whey proteins. Food Chem 114:440–446 (2009).
26. Le Maux S, Nongonierma AB, Murray B, Kelly PM and FitzGerald RJ, Identification of short peptide sequences in the nanofiltration permeate of a bioactive whey protein hydrolysate. Food Res Int 77:534–539 (2015).
27. Contreras MdM, Hernández-Ledesma B, Amigo L, Martín-Álvarez PJ and Recio I, Production of antioxidant hydrolyzates from a whey protein concentrate with thermolysin: Optimization by response surface methodology. LWT – Food Sci Technol 44:9–15 (2011).
28. Guo Y, Pan D and Tanokura M, Optimisation of hydrolysis conditions for the production of the angiotensin-I converting enzyme (ACE) inhibitory peptides from whey protein using response surface methodology. Food Chem 114:328-3-33 (2009).
29. Tavares TG, Contreras MM, Amorim M, Martín-Álvarez PJ, Pintado ME, Recio I, et al., Optimisation, by response surface methodology, of degree of hydrolysis and antioxidant and ACE-inhibitory activities of whey protein hydrolysates obtained with cardoon extract. Int Dairy J 21:926-9-33 (2011).
30. Vermeirssen V, Van Camp J, Devos L and Verstraete W, Release of angiotensin I converting enzyme (ACE) inhibitory activity during in vitro gastrointestinal digestion: from batch experiment to semicontinuous model. J Agric Food Chem 51:5680–5687 (2003).
31. Pan D and Guo Y, Optimization of sour milk fermentation for the production of ACE-inhibitory peptides and purification of a novel peptide from whey protein hydrolysate. Int Dairy J 20:472–479 (2010).
32. Zhao X-H and Li Y-Y, An approach to improve ACE-inhibitory activity of casein hydrolysates with plastein reaction catalyzed by Alcalase. Eur Food Res Technol 229:795–805 (2009).
33. Uluko H, Li H, Cui W, Zhang S, Liu L, Chen J, et al., Response surface optimization of angiotensin converting enzyme inhibition of milk protein concentrate hydrolysates in vitro after ultrasound pretreatment. Innov Food Sci Emerg Technol 20:133–139 (2013).
34. Liu X, Luo Y and Li Z, Effects of pH, temperature, enzyme-to-substrate ratio and reaction time on the antigenicity of casein hydrolysates prepared by papain, Food Agric Immunol 23:69–82 (2012).
35. Zhao XH, Wu D and Li TJ, Preparation and radical scavenging activity of papain-catalyzed casein plasteins. Dairy Sci Technol 90:521–535 (2010).
36. Smyth M and FitzGerald RJ, Relationship between some characteristics of WPC hydrolysates and the enzyme complement in commercially available proteinase preparations. Int Dairy J 8:819–827 (1998).
37. Sindayikengera S, Nutritional evaluation of caseins and whey proteins and their hydrolysates from Protamex. J Zhejiang Univ Sci B 7:90–98 (2006).
38. Nongonierma AB and FitzGerald RJ, Structure activity relationship modelling of milk protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity. Peptides 79:1–7 (2016).
39. Nongonierma AB and FitzGerald RJ, Inhibition of dipeptidyl peptidase IV (DPP-IV) by proline containing peptides. J Funct Foods 5:1909–1917 (2013).
40. Lan VTT, Ito K, Ito S and Kawarasaki Y, Trp-Arg-Xaa tripeptides act as uncompetitive-type inhibitors of human dipeptidyl peptidase IV. Peptides 54:166–170 (2014).
41. Pihlanto A, Antioxidative peptides derived from milk proteins. Int Dairy J 16:1306–1314 (2006).
42. Hernández-Ledesma B, Amigo L, Recio I and Bartolomé B ACE-inhibitory and radical-scavenging activity of peptides derived from β-lactoglobulin f (19–25). Interactions with ascorbic acid. J Agric Food Chem 55:3392–3397 (2007).
43. Silveira ST, Martínez-Maqueda D, Recio I and Hernández-Ledesma B, Dipeptidyl peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin. Food Chem 141:1072–1077 (2013).
44. Lacroix IME and Li-Chan ECY, Isolation and characterization of peptides with dipeptidyl peptidase-IV inhibitory activity from pepsin-treated bovine whey proteins. Peptides 54:39–48 (2014).
45. Kühn-Wache K, Bär JW, Hoffmann T, Wolf R, Rahfeld J-U and Demuth H-U, Selective inhibition of dipeptidyl peptidase 4 by targeting a substrate-specific secondary binding site. Biol Chem 392:223–231 (2011).
46. Lorey S, Stöckel-Maschek A, Faust J, Brandt W, Stiebitz B, Gorrell MD, et al., Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites. Eur J Biochem 270:2147–2156 (2003).
47. Nongonierma AB, Mooney C, Shields DC and FitzGerald RJ, Inhibition of dipeptidyl peptidase IV and xanthine oxidase by amino acids and dipeptides. Food Chem 141:644–653 (2013).
48. Thoma R, Löffler B, Stihle M, Huber W, Ruf A and Hennig M, Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV. Structure 11:947–959 (2003).
49. Velarde-Salcedo AJ, Barrera-Pacheco A, Lara-González S, Montero-Morán GM, Díaz-Gois A, González de Mejia E, et al., In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth (Amaranthus hypochondriacus L.) proteins. Food Chem 136:758–764 (2013).
50. López-Expósito I, Quirós A, Amigo L and Recio I, Casein hydrolysates as a source of antimicrobial, antioxidant and antihypertensive peptides. Le Lait 87:241–249 (2007).
51. Lacroix IM and Li-Chan ECY, Inhibition of dipeptidyl peptidase (DPP)-IV and α-glucosidase activities by pepsin-treated whey proteins. J Agric Food Chem 61:7500–7506 (2013).
52. Nongonierma AB and FitzGerald RJ, The scientific evidence for the role of milk protein-derived bioactive peptides in humans: A Review. J Funct Foods 640:640–656 (2015).
53. Nongonierma AB and FitzGerald RJ, Bioactive properties of milk proteins in humans: A review. Peptides 73:20–34 (2015).
54. Mochida T, Hira T and Hara H, The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats. Endocrinology 151:3095–3104 (2010).
55. Hsieh C, Wang T, Hung C, Chen M and Hsu K, Improvement of glycemic control in streptozotocin-induced diabetic rats by Atlantic salmon skin gelatin hydrolysate as the dipeptidyl-peptidase IV inhibitor. Food Funct 6:1887–1892 (2015).
56. Huang S-L, Hung C-C, Jao C-L, Tung Y-S and Hsu K-C, Porcine skin gelatin hydrolysate as a dipeptidyl peptidase IV inhibitor improves glycemic control in streptozotocin-induced diabetic rats. J Funct Foods 11:235–242 (2014).
57. Wang T-Y, Hsieh C-H, Hung C-C, Jao C-L, Chen M-C and Hsu K-C, Fish skin gelatin hydrolysates as dipeptidyl peptidase IV inhibitors and glucagon-like peptide-1 stimulators improve glycaemic control in diabetic rats: A comparison between warm- and cold-water fish. J Funct Foods 19(Part A):330–340 (2015).